Your Patient Needs Clindamycin — And Their Pharmacy Is Out. Here's How to Help.

As a prescriber, few things are more frustrating than writing a prescription and learning your patient can't get it filled. When a patient calls back to say their pharmacy doesn't have Clindamycin, you need a quick, practical game plan to get them treated.

This guide gives you a step-by-step approach to helping patients navigate Clindamycin availability issues — from finding stock to switching alternatives when necessary.

Current Availability: What You Need to Know

Here's the availability landscape for Clindamycin in 2026:

• Injectable Clindamycin Phosphate: On the ASHP shortage list. Sagent 150 mg/mL 60 mL vials are on back order with no estimated release. Pfizer Cleocin injectables have intermittent availability. Baxter premixed IV bags are under allocation.
• Oral capsules (150 mg, 300 mg): Generally available from multiple generic manufacturers. Local stock-outs may occur but are typically temporary.
• Oral solution (75 mg/5 mL): Available — important for pediatric patients.
• Topical formulations (1%): Available — gel, lotion, foam (Evoclin), solution.
• Vaginal formulations: Available — 2% cream, suppositories, and Xaciato single-dose gel.

For the full shortage timeline and manufacturer details, see our companion article: Clindamycin Shortage: What Providers and Prescribers Need to Know in 2026.

Why Patients Can't Find It

Understanding the root causes helps you counsel patients effectively:

• Distributor allocation limits: Pharmacies may only be able to order limited quantities of certain Clindamycin products at a time
• Ripple effect from injectable shortage: When hospitals can't get IV Clindamycin, some patients are transitioned to oral forms, increasing retail demand
• Regional variation: Availability is inconsistent across geographic areas. Rural pharmacies and areas with fewer wholesalers are more likely to experience gaps.
• Timing: A patient arriving at the pharmacy late in the week may find that stock ordered on Monday has already been dispensed

What Providers Can Do: 5 Practical Steps

Step 1: Direct Patients to Medfinder

The single most effective thing you can do is send patients to Medfinder. Medfinder allows patients to search for pharmacies that have Clindamycin in stock by entering their zip code. This eliminates the need for patients to call pharmacy after pharmacy — and reduces the callback volume to your office.

Consider including the Medfinder link in your after-visit summary or patient portal messaging for any prescription that may be subject to availability issues.

Step 2: Prescribe to a Specific Pharmacy With Stock

If your patient has already used Medfinder or called around and identified a pharmacy with Clindamycin in stock, send the prescription directly to that pharmacy. This is more efficient than having the patient try to transfer a prescription from a pharmacy that doesn't have it.

Step 3: Consider Dose or Formulation Flexibility

If a specific strength or formulation is unavailable, a minor adjustment may solve the problem:

• If 300 mg capsules are out of stock, prescribe two 150 mg capsules per dose instead
• If capsules are unavailable, consider the oral solution (75 mg/5 mL) — especially for patients who can't swallow capsules anyway
• If topical gel is out of stock, topical lotion or solution formulations of 1% Clindamycin may be available

Step 4: Have an Alternative Ready

When switching is clinically appropriate, having a pre-determined alternative streamlines the process. Based on the infection type:

• Skin/soft tissue (including MRSA): Doxycycline 100 mg BID or Trimethoprim/Sulfamethoxazole DS BID
• Dental infections: Metronidazole 500 mg TID or Amoxicillin/Clavulanate 875/125 mg BID (if no penicillin allergy)
• Pelvic/gynecological infections: Metronidazole 500 mg BID (vaginal or oral)
• Acne (topical): Benzoyl Peroxide, Adapalene, topical Erythromycin, or topical Dapsone
• Surgical prophylaxis: Vancomycin 1g IV or institution-specific protocol

Share the patient-facing version with patients: Alternatives to Clindamycin If You Can't Fill Your Prescription.

Step 5: Recommend Independent Pharmacies

If your practice is in an area where chain pharmacies frequently experience stock-outs, maintain a short list of local independent pharmacies. Independent pharmacies often:

• Use different wholesale distributors than national chains
• Have more flexibility to place rush orders
• May have access to supply sources that chains don't

Compounding pharmacies can also prepare custom Clindamycin formulations when standard products are unavailable.

Alternatives at a Glance

Quick reference for Clindamycin alternatives by indication:

• Azithromycin: Respiratory infections, skin infections, STIs. Once-daily dosing. Lower C. diff risk. Limited anaerobic coverage.
• Doxycycline: Skin/soft tissue (MRSA), acne, respiratory infections. Avoid in pregnancy and children under 8. Sun sensitivity.
• Metronidazole: Anaerobic infections, dental, pelvic, BV, C. diff treatment. No alcohol during treatment. No gram-positive aerobic coverage.
• Amoxicillin/Clavulanate: Broad-spectrum including anaerobes. Contraindicated in penicillin allergy. GI side effects common.

For detailed comparison: How Does Clindamycin Work? Mechanism of Action Explained.

Workflow Tips for Your Practice

To minimize disruption when shortages affect your patients:

• Add a shortage flag in your EHR for medications currently on the ASHP shortage list to prompt proactive counseling at the point of prescribing
• Prepare templated messages for your patient portal that include the Medfinder link and alternative pharmacy suggestions
• Brief your clinical staff on the current availability status so medical assistants and nurses can answer patient questions without needing a physician callback
• Review your preferred alternatives with your pharmacy colleagues to ensure alignment on substitution protocols
• Document shortage-related changes in the medical record, noting the clinical rationale for any therapeutic substitution

Final Thoughts

Clindamycin availability issues in 2026 are manageable with the right approach. The injectable shortage continues to be the primary concern, while oral and topical formulations remain accessible. By directing patients to Medfinder, maintaining alternative protocols, and leveraging independent pharmacy networks, you can ensure your patients get the treatment they need without unnecessary delays.

For the complete shortage briefing with timeline and manufacturer data, see: Clindamycin Shortage: What Providers and Prescribers Need to Know in 2026.

For patient-facing cost and savings information to share: How to Help Patients Save Money on Clindamycin: A Provider's Guide.